Singapore: Daiichi Sankyo received approval for a supplemental new drug application (sNDA) for an additional indication for Topotecin intravenous drip infusion 40... Read more
Singapore: Daiichi Sankyo has announced a new five-year business plan, which will span from April 1, 2013 through March 31, 2018. As part of the new plan, the company... Read more
Singapore: Japanese company Nippon Telegraph and Telephone Corporation (NTT) has developed a conductive fiber by coating the surface of silk or synthetic fiber with... Read more
Singapore: NPS Pharma has re-gained the full worldwide rights to teduglutide and recombinant human parathyroid hormone 1-84 (PTH 1-84) from Takeda Pharma. NPS licensed... Read more
Big pharma companies are gearing up to combat the shortage of injectables in the US through acquiring companies with approved manufacturing facilities. Last month,... Read more
Singapore: Wyss Institute for Biologically Inspired Engineering at Harvard University has collaborated with Sony DADC, disc and digital service provider, for utilizing... Read more
Singapore: Dainippon Sumitomo Pharma (DSP), headquartered in Japan, and Nippon Shinyaku, also a Japanese company, have concluded a license agreement for exclusive... Read more
Singapore: Japanese company Daiichi Sankyo has received positive results for a double-blind randomized phase III trial comparing efficacy and safety of prasugrel... Read more
Singapore: The Scripps Research Institute (TSRI) and Takeda Pharmaceutical plan to expand their recent research collaboration to search for new drug targets for... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
